Logo.png
Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference
05 sept. 2023 08h00 HE | Cocrystal Pharma, Inc.
BOTHELL, Wash., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing novel...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Antiviral Drugs Market Size Is Valued At USD 71.1 Bn by 2032 | CAGR of 3.73%
06 avr. 2023 09h42 HE | Market.Us
New York, April 06, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the antiviral drugs market size is projected to surpass around USD 71.1 billion by 2032 from USD 49.8 billion in 2022, and it is...
visiongain Logo.png
Antiviral drugs market is projected to grow at a CAGR of 3.49% by 2032: Visiongain Reports Ltd
09 janv. 2023 06h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
visiongain Logo.png
Antiviral drugs market is projected to grow at a CAGR of 3.49% by 2032: Visiongain Reports Ltd
25 nov. 2022 12h07 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
Roots-Analysis-Logo.png
The antiviral drugs market is anticipated to grow at a CAGR of 6.3% during the period 2022-2035, claims Roots Analysis
01 nov. 2022 15h00 HE | Roots Analysis
London, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Antiviral Drugs Market, 2022 – 2035” report to its list of offerings. The recent COVID-19 pandemic has...
Dr. William Haseltine releases new book on Innate Immunity and Covid-19
16 mars 2022 13h37 HE | ACCESS Health International
New York, March 16, 2022 (GLOBE NEWSWIRE) -- In his latest book, bestselling author William A. Haseltine Ph.D. tells us that understanding our natural immunity to the SARS-CoV-2 virus is critical...
visiongain Logo.png
Alzheimer’s Drugs Market Report to 2031: Visiongain Research Inc.
19 juil. 2021 09h00 HE | Visiongain Ltd
Visiongain has published a new report on Alzheimer’s Drugs Market Report to 2031: Forecasts by Drugs (Donepezil, Rivastigmine, Galantamine, and Memantine), By Distribution Channel (Hospital...
visiongain-logo-72dpi.jpg
Global Antiviral Drugs Treatment Market is forecast to reach a market value of US$74.88 billion by 2031
27 mai 2021 05h09 HE | Visiongain Ltd
Visiongain has published a new report on Antiviral Drugs Treatment Market Report 2021-2031. Profiles of Antiviral Drugs Treatment and Forecasts By Drug Class (DNA Ploymerase Inhibitors, Reverse...
ARC logo.png
Antiviral Drugs Market Value Projected To Reach US$ 74.7 Billion By 2027: Acumen Research And Consulting
01 avr. 2021 11h16 HE | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Antiviral Drugs Market– Global Industry Analysis, Market Size, Opportunities and...
gmi logo.jpg
Antiviral Drugs Market revenue to cross USD 44.5 Bn by 2027: Global Market Insights Inc.
08 mars 2021 05h00 HE | Global Market Insights, Inc
Selbyville, Delaware, March 08, 2021 (GLOBE NEWSWIRE) -- According to latest report “Antiviral Drugs Market By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease...